Allogeneic NK-92 Cells: Advancing from Pre-Clinical Development to Clinical Application
Time: 10:00 am
day: Day One
Details:
- Recapping the pre-clinical development of NK-92 and its clonal ‘offsprings’
- Showcasing the outcome of first clinical studies
- Reviewing novel NK-92 based variants expressing FcR, CARs and immune modulators
